Merit Medical Systems ROE 2010-2024 | MMSI
Current and historical return on equity (ROE) values for Merit Medical Systems (MMSI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Merit Medical Systems ROE - Return on Equity Historical Data |
Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
2024-09-30 |
$0.12B |
$1.32B |
9.51% |
2024-06-30 |
$0.12B |
$1.28B |
9.53% |
2024-03-31 |
$0.10B |
$1.24B |
8.37% |
2023-12-31 |
$0.10B |
$1.20B |
7.90% |
2023-09-30 |
$0.10B |
$1.23B |
8.42% |
2023-06-30 |
$0.09B |
$1.20B |
7.72% |
2023-03-31 |
$0.08B |
$1.17B |
7.50% |
2022-12-31 |
$0.07B |
$1.14B |
6.78% |
2022-09-30 |
$0.06B |
$1.09B |
5.82% |
2022-06-30 |
$0.06B |
$1.07B |
5.64% |
2022-03-31 |
$0.05B |
$1.06B |
4.78% |
2021-12-31 |
$0.05B |
$1.04B |
4.87% |
2021-09-30 |
$0.04B |
$1.01B |
4.36% |
2021-06-30 |
$0.03B |
$0.99B |
2.90% |
2021-03-31 |
$0.00B |
$0.98B |
0.42% |
2020-12-31 |
$-0.01B |
$0.96B |
-1.06% |
2020-09-30 |
$-0.03B |
$0.93B |
-3.09% |
2020-06-30 |
$-0.03B |
$0.93B |
-3.08% |
2020-03-31 |
$-0.00B |
$0.94B |
-0.32% |
2019-12-31 |
$0.01B |
$0.95B |
0.63% |
2019-09-30 |
$0.02B |
$0.95B |
2.01% |
2019-06-30 |
$0.04B |
$0.95B |
4.16% |
2019-03-31 |
$0.04B |
$0.94B |
4.92% |
2018-12-31 |
$0.04B |
$0.93B |
5.18% |
2018-09-30 |
$0.04B |
$0.92B |
5.36% |
2018-06-30 |
$0.02B |
$0.70B |
2.78% |
2018-03-31 |
$0.02B |
$0.69B |
2.52% |
2017-12-31 |
$0.03B |
$0.68B |
4.06% |
2017-09-30 |
$0.03B |
$0.67B |
4.51% |
2017-06-30 |
$0.03B |
$0.67B |
5.73% |
2017-03-31 |
$0.03B |
$0.65B |
5.86% |
2016-12-31 |
$0.02B |
$0.50B |
4.13% |
2016-09-30 |
$0.02B |
$0.49B |
3.78% |
2016-06-30 |
$0.02B |
$0.48B |
4.69% |
2016-03-31 |
$0.02B |
$0.47B |
4.76% |
2015-12-31 |
$0.02B |
$0.47B |
5.05% |
2015-09-30 |
$0.03B |
$0.46B |
5.81% |
2015-06-30 |
$0.03B |
$0.45B |
6.61% |
2015-03-31 |
$0.03B |
$0.44B |
6.05% |
2014-12-31 |
$0.02B |
$0.44B |
5.70% |
2014-09-30 |
$0.02B |
$0.42B |
5.31% |
2014-06-30 |
$0.02B |
$0.42B |
4.91% |
2014-03-31 |
$0.02B |
$0.41B |
4.99% |
2013-12-31 |
$0.02B |
$0.41B |
4.57% |
2013-09-30 |
$0.01B |
$0.40B |
3.09% |
2013-06-30 |
$0.01B |
$0.39B |
3.39% |
2013-03-31 |
$0.02B |
$0.38B |
3.96% |
2012-12-31 |
$0.02B |
$0.38B |
5.34% |
2012-09-30 |
$0.02B |
$0.38B |
6.52% |
2012-06-30 |
$0.02B |
$0.37B |
6.10% |
2012-03-31 |
$0.02B |
$0.36B |
6.49% |
2011-12-31 |
$0.02B |
$0.36B |
7.38% |
2011-09-30 |
$0.02B |
$0.35B |
7.80% |
2011-06-30 |
$0.02B |
$0.35B |
6.04% |
2011-03-31 |
$0.02B |
$0.25B |
6.36% |
2010-12-31 |
$0.01B |
$0.24B |
5.65% |
2010-09-30 |
$0.01B |
$0.23B |
6.20% |
2010-06-30 |
$0.02B |
$0.23B |
9.94% |
2010-03-31 |
$0.02B |
$0.22B |
10.24% |
2009-12-31 |
$0.02B |
$0.22B |
11.04% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$5.972B |
$1.257B |
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|